Elevance Health
Operator of Anthem and Wellpoint health plans plus Carelon pharmacy and care services.
$397.30
After-hours close+2.82 (+0.72%)
At close$394.48(−1.16%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 149.82%Insiders 0.18%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 216.87M · Float 216.41M · 99.8% free float
Institutions13F, as of Jun 30, 2026
1,667 holders · 324.91M shares · 271 new positions · 861 increased · 546 reduced · 125 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 18.99M | 8.76% | −896.0K | Aug 7, 2026 |
| Vanguard Capital Management LLC | 14.06M | 6.48% | −287.3K | Aug 13, 2026 |
| State Street Corp | 10.43M | 4.81% | +137.9K | Aug 7, 2026 |
| Wellington Management Group LLP | 9.21M | 4.25% | +985.0K | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 6.21M | 2.87% | −141.7K | Aug 13, 2026 |
| Sanders Capital, LLC | 5.83M | 2.69% | −69.3K | Aug 10, 2026 |
| Geode Capital Management, LLC | 5.17M | 2.38% | −26.6K | Aug 12, 2026 |
| Harris Associates L P | 4.92M | 2.27% | +128.0K | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 7.80% | 17.69M | 13G | Apr 17, 2025 ↗ |
| Vanguard Capital Management | 7.13% | 16.60M | 13G | Apr 29, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Gail Boudreaux | director, officer: President and CEO | 169.9K | 0.08% | Jul 17, 2026 |
| Felicia F. Norwood | officer: EVP &Chief Health Benefits Ofr | 38.8K | 0.02% | Mar 4, 2026 |
| Mark Kaye | officer: EVP & CFO | 32.0K | 0.01% | Mar 4, 2026 |
| Peter D. Haytaian | officer: EVP & Pres Carelon & CarelonRx | 27.2K | 0.01% | Mar 4, 2026 |
| Ratnakar Lavu | officer: EVP & Chief Digital Info Ofr | 16.1K | 0.01% | Mar 4, 2026 |
| Lewis Iii Hay | director | 12.1K | 0.01% | May 15, 2026 |
| Charles Morgan JR Kendrick | officer: EVP & President, Commercial | 11.8K | 0.01% | Mar 9, 2026 |
| Ramiro G. Peru | director | 10.9K | 0.01% | Jul 17, 2026 |
| Robert L. JR Dixon | director | 10.7K | 0.00% | Jun 12, 2026 |
| R. Kerry Clark | director | 9.6K | 0.00% | May 16, 2025 |
37 people have not refiled in the last 18 months (1.78M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 17, 2026 | Gail Boudreauxdirector, officer: President and CEO | Purchase · 2 lots | 2,725 | $367.79 | 171,976 |
| Jul 17, 2026 | Ramiro G. Perudirector | Purchase | 1,000 | $366.05 | 10,908 |
| Jun 12, 2026 | Ronald W. Penczekofficer: CAO & Controller | Sale | 369 | $403.16 | 3,740 |
| Jun 11, 2026 | Robert L. JR Dixondirector | Sale | 151 | $401.77 | 10,734 |
| May 19, 2026 | Ronald W. Penczekofficer: CAO & Controller | Sale | 1,531 | $403.13 | 4,109 |
| Mar 12, 2026 | Amy W. Schulmandirector | Sale | 26 | $287.50 | 218 |
| Mar 6, 2026 | Charles Morgan JR Kendrickofficer: EVP & President, Commercial | Sale | 3,196 | $284.92 | 11,791 |
| Mar 5, 2026 | Steven H. Collisdirector | Purchase | 3,000 | $289.84 | 3,639 |
CongressHouse and Senate disclosures
Not reported.